Nanotechnology
The Division of Cancer Treatment and Diagnosis (DCTD) supports research of established and emerging nanotechnology methods aimed at advancing cancer prevention, diagnosis, and treatment. Nanotechnology, which utilizes nanoparticles and nano-devices typically one hundred to ten thousand times smaller than human cells, enables researchers to address critical cancer-related challenges, such as developing diagnostic devices and sensors in vitro and achieving effective drug delivery to cancer targets in vivo. Significant progress has been made in implementing nano-based cancer therapies and diagnostics in the clinic, with many more interventions under development.
Nanotechnology Research
-
Cancer and Nanotechnology
Nanotechnology enables earlier cancer detection, improves imaging capabilities for diagnosis and treatment monitoring, and improves therapeutic outcomes through effective targeting and reduced toxicity.
-
Nanotechnology Characterization Laboratory
The Nanotechnology Characterization Laboratory is a collaborative effort between NCI, FDA, and NIST that provides preclinical characterization and safety testing of nanoparticles.